Work

Prophylactic doxycycline (doxy) lessens rash from dacomitinib (D) an EGFR inhibitor with no rash or diarrhea improvement from corticosteroids or probiotics.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e19049

Authors: Mario E. Lacouture, Dorothy Mary Kate Keefe, Stephen T. Sonis, Nagdeep Giri, Tao Wang, Arlene Reisman, Eric Sbar, Diana R. Gernhardt, Aminah Jatoi

Institutions: Memorial Sloan Kettering Cancer Center, Royal Adelaide Hospital, Dana-Farber Cancer Institute, Pfizer (United States), Mayo Clinic

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602148130

Cites:

Cited by: 2

Related to: 10